BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

  October 17, 2025

   · 

  4 min read
• Press Releases

  IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

  October 17, 2025

   · 

  3 min read
• Press Releases

  Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group

  October 17, 2025

   · 

  3 min read
• Press Releases

  ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program

  October 17, 2025

   · 

  6 min read
• Press Releases

  Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis

  October 17, 2025

   · 

  3 min read
• Press Releases

  Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

  October 17, 2025

   · 

  4 min read
• Press Releases

  Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

  October 17, 2025

   · 

  4 min read
• Press Releases

  Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

  October 17, 2025

   · 

  4 min read
• Press Releases

  OmniAb to Participate in Three Investor Conferences in November 2025

  October 17, 2025

   · 

  2 min read
• Press Releases

  Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

  October 17, 2025

   · 

  16 min read